Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression

The recent questioning of the antidepressant effect of selective serotonin reuptake inhibitors (SSRIs) is partly based on the observation that approximately half of company-sponsored trials have failed to reveal a significant difference between active drug and placebo. Most of these have applied the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hieronymus, F, Emilsson, J F, Nilsson, S, Eriksson, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804177/
https://www.ncbi.nlm.nih.gov/pubmed/25917369
http://dx.doi.org/10.1038/mp.2015.53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804177/
https://www.ncbi.nlm.nih.gov/pubmed/25917369
http://dx.doi.org/10.1038/mp.2015.53

Ejemplares similares